PUBLICATIONS · 3902203
A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Cancer
- Publication date
- 1985 Nov 1
- First author
- Shimaoka K
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shimaoka K
- type
- Author
- name
- Schoenfeld DA
- type
- Author
- name
- DeWys WD
- type
- Author
- name
- Creech RH
- type
- Author
- name
- DeConti R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shimaoka K
- type
- Author
- name
- Schoenfeld DA
- type
- Author
- name
- DeWys WD
- type
- Author
- name
- Creech RH
- type
- Author
- name
- DeConti R
- type
- Author
- bibliography ids
- nci-bib-5e2854e9f263e82f69fddc11
- book metadata
- content sha256
- 65482a4d9da715051b51efc29f0ef1249f6f54b00828871bff547953fb01e84d
- document type
- citation
- dois
- 10.1002/1097-0142(19851101)56:9<2155::aid-cncr2820560903>3.0.co;2-e
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:3902203
- immutable id
- pubmed:3902203@65482a4d9da715051b51efc29f0ef1249f6f54b00828871bff547953fb01e84d
- journal
- abbreviation
- Cancer
- issn electronic
- Source null
- issn print
- 0008-543X
- issue
- 9
- name
- Cancer
- nlm unique id
- 0374236
- pages
- 2155-60
- volume
- 56
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 3902203
- provenance
- batch id
- 45403cd8e23f91d9edb9
- provider
- NCBI PubMed ESummary
- record sha256
- 861e473a1065ebfa1b087a154a7abce408fa2cd09a7034bc5ed46ad867de4b87
- response sha256
- 67aea2123a1ac51343b6dac62187e007efabbd6172b000ecba1c9d0afe20513a
- retrieved at
- 2026-09-09T23:45:14.686855+00:00
- publication date
- display
- 1985 Nov 1
- precision
- day
- year
- 1985
- publication types
- Clinical Trial
- Comparative Study
- Journal Article
- Randomized Controlled Trial
- Research Support, U.S. Gov't, P.H.S.
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/3902203/
- title
- A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma.
Preserved source evidence · Not medical advice
Triangle